
Selatinib is a reversible and orally active dual EGFR and ErbB2 ингибитор with IC50s of 13 nM and 22.5 nM, respectively. Selatinib has anticancer effects.
Selatinib is a reversible and orally active dual EGFR and ErbB2 inhibitor with IC50s of 13 nM and 22.5 nM, respectively. Selatinib has anticancer effects.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.